INS and type 2 diabetes mellitus: The T2DM patients carrying the ApoE ε4 allele exhibit heightened activation of platelet glycogen synthase kinase‐3β (GSK‐3β), a key downstream kinase in the insulin signaling pathway, along with more severe cognitive deficits.